Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Clinical trial management system industry 3600 synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Component trends
2.1.3 Product trends
2.1.4 Delivery mode trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Clinical trial management system (CTMS) Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing chronic disease prevalence, effective medicine demand and modern technology adoption
3.3.1.2 Growing research and development activities
3.3.1.3 Increasing number of clinical trials
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost of clinical trial management system
3.4 Growth potential analysis
3.4.1 By component
3.4.2 By product
3.4.3 By delivery mode
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Software landscape
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.7.3 China
3.8 Porter’s analysis
3.9 Competitive landscape
3.9.1 Company matrix analysis, 2021
3.10 PESTEL analysis
Chapter 4 Clinical trial management system (CTMS) Market, By Component
4.1 Key segment trends
4.2 Software
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Services
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Clinical trial management system (CTMS) Market, By Product
5.1 Key segment trends
5.2 Enterprise-based
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Site-based
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Clinical trial management system (CTMS) Market, By Delivery Mode
6.1 Key segment trends
6.2 Web-based
6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Cloud-based
6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 On premise
6.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Clinical trial management system (CTMS) Market, By End-use
7.1 Key segment trends
7.2 Pharmaceutical & biopharmaceutical companies
7.2.1 Market size, by region, 2017 - 2030 (USD Million)
7.3 Clinical research organization (CRO)
7.3.1 Market size, by region, 2017 - 2030 (USD Million)
7.4 Others
7.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Clinical trial management system (CTMS) Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2017 - 2030 (USD Million)
8.2.2 Market size, by component, 2017 - 2030 (USD Million)
8.2.3 Market size, by product, 2017 - 2030 (USD Million)
8.2.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.2.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.2.6 U.S.
8.2.6.1 Market size, by component, 2017 - 2030 (USD Million)
8.2.6.2 Market size, by product, 2017 - 2030 (USD Million)
8.2.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.2.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.2.7 Canada
8.2.7.1 Market size, by component, 2017 - 2030 (USD Million)
8.2.7.2 Market size, by product, 2017 - 2030 (USD Million)
8.2.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2017 - 2030 (USD Million)
8.3.2 Market size, by component, 2017 - 2030 (USD Million)
8.3.3 Market size, by product, 2017 - 2030 (USD Million)
8.3.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.3.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.6 Germany
8.3.6.1 Market size, by component, 2017 - 2030 (USD Million)
8.3.6.2 Market size, by product, 2017 - 2030 (USD Million)
8.3.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.3.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.7 UK
8.3.7.1 Market size, by component, 2017 - 2030 (USD Million)
8.3.7.2 Market size, by product, 2017 - 2030 (USD Million)
8.3.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.8 France
8.3.8.1 Market size, by component, 2017 - 2030 (USD Million)
8.3.8.2 Market size, by product, 2017 - 2030 (USD Million)
8.3.8.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by component, 2017 - 2030 (USD Million)
8.3.9.2 Market size, by product, 2017 - 2030 (USD Million)
8.3.9.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.3.10 Italy
8.3.10.1 Market size, by component, 2017 - 2030 (USD Million)
8.3.10.2 Market size, by product, 2017 - 2030 (USD Million)
8.3.10.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2017 - 2030 (USD Million)
8.4.2 Market size, by component, 2017 - 2030 (USD Million)
8.4.3 Market size, by product, 2017 - 2030 (USD Million)
8.4.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.4.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.4.6 China
8.4.6.1 Market size, by component, 2017 - 2030 (USD Million)
8.4.6.2 Market size, by product, 2017 - 2030 (USD Million)
8.4.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.4.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.4.7 Japan
8.4.7.1 Market size, by component, 2017 - 2030 (USD Million)
8.4.7.2 Market size, by product, 2017 - 2030 (USD Million)
8.4.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.4.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.4.8 India
8.4.8.1 Market size, by component, 2017 - 2030 (USD Million)
8.4.8.2 Market size, by product, 2017 - 2030 (USD Million)
8.4.8.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.4.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.4.9 Australia
8.4.9.1 Market size, by component, 2017 - 2030 (USD Million)
8.4.9.2 Market size, by product, 2017 - 2030 (USD Million)
8.4.9.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.4.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2017 - 2030 (USD Million)
8.5.2 Market size, by component, 2017 - 2030 (USD Million)
8.5.3 Market size, by product, 2017 - 2030 (USD Million)
8.5.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.5.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.5.6 Brazil
8.5.6.1 Market size, by component, 2017 - 2030 (USD Million)
8.5.6.2 Market size, by product, 2017 - 2030 (USD Million)
8.5.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.5.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.5.7 Mexico
8.5.7.1 Market size, by component, 2017 - 2030 (USD Million)
8.5.7.2 Market size, by product, 2017 - 2030 (USD Million)
8.5.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.5.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.6 MEA
8.6.1 Market size, by country, 2017 - 2030 (USD Million)
8.6.2 Market size, by component, 2017 - 2030 (USD Million)
8.6.3 Market size, by product, 2017 - 2030 (USD Million)
8.6.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.6.5 Market size, by end-use, 2017 - 2030 (USD Million)
8.6.6 South Africa
8.6.6.1 Market size, by component, 2017 - 2030 (USD Million)
8.6.6.2 Market size, by product, 2017 - 2030 (USD Million)
8.6.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.6.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
8.6.7 Saudi Arabia
8.6.7.1 Market size, by component, 2017 - 2030 (USD Million)
8.6.7.2 Market size, by product, 2017 - 2030 (USD Million)
8.6.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
8.6.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
9.1 Competitive dashboard
9.2 Clario
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Advarra
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Datatrak Inc
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 PHARMASEAL
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 SimpleTrials
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 MasterControl Inc
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Medidata Solution Inc (Dassault Systemes)
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 MedNet Solution Inc
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Merge Healthcare (IBM Watson)
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Anju Software Inc
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 Oracle Corporation
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 SWOT analysis
9.13 Paraxel International
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Product landscape
9.13.4 Strategic outlook
9.13.5 SWOT analysis
9.14 Veeva System
9.14.1 Business overview
9.14.2 Financial data
9.14.3 Product landscape
9.14.4 Strategic outlook
9.14.5 SWOT analysis
